Una dieta baja en carbohidratos fermentables de cadena corta ante la sensibilidad al gluten ¿el siguiente paso?

Dr. William F. Balistreri

Conflictos de interés

18 de octubre de 2017

En este contenido

Referencias

  1. Aziz I, Branchi F, Sanders D. The rise and fall of gluten! Proc Nutr Soc. Ago 2015;74(3):221-226. doi: 10.1017/S0029665115000038. PMID: 25686620. Artículo

  2. Fasano A, Sapone A, Zevallos V, Schuppan D. Nonceliac gluten sensitivity. Gastroenterology. May 2015;148(6):1195-1204. doi: 10.1053/j.gastro.2014.12.049. PMID: 25583468. Resumen

  3. Lebwohl B, Ludvigsson JF, Green PH. Celiac disease and non-celiac gluten sensitivity. BMJ. 5 Oct 2015;351:h4347. doi: 10.1136/bmj.h4347. PMID: 26438584. Resumen

  4. Biesiekierski JR, Newnham ED, Shepherd SJ, Muir JG, y cols. Characterization of adults with a self-diagnosis of nonceliac gluten sensitivity. Nutr Clin Pract. Ago 2014;29(4):504-509. doi: 10.1177/0884533614529163. PMID: 24740495. Resumen

  5. Meijer CR, Shamir R, Mearin ML. Coeliac disease and noncoeliac gluten sensitivity. J Pediatr Gastroenterol Nutr. Abr 2015;60(4):429-432. doi: 10.1097/MPG.0000000000000708. PMID: 25564803. Resumen

  6. Di Sabatino A, Corazza GR. Nonceliac gluten sensitivity: sense or sensibility? Ann Intern Med. 21 Feb 2012;156(4):309-311. doi: 10.7326/0003-4819-156-4-201202210-00010. PMID: 22351716. Resumen

  7. Zanini B, Baschè R, Ferraresi A, Ricci C, y cols. Randomised clinical study: gluten challenge induces symptom recurrence in only a minority of patients who meet clinical criteria for non-coeliac gluten sensitivity. Alimnet Pharmacol Ther. Oct 2015;42(8):968-976. doi: 10.1111/apt.13372. PMID: 26310131. Artículo

  8. Huebener S, Tanaka CK, Uhde M, Zone JJ, y cols. Specific nongluten proteins of wheat are novel target antigens in celiac disease humoral response. J Proteome Res. 2 Ene 2015;14(1):503-511. doi: 10.1021/pr500809b. PMID: 25329597. Resumen

  9. Biesiekierski JR, Peters SL, Newnham ED, Rosella O, y cols. No effects of gluten in patients with self-reported nonceliac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology. Ago 2013;145(2):320-328. doi: 10.1053/j.gastro.2013.04.051. PMID: 23648697. Artículo

  10. Gibson, PR. History of the low FODMAP diet. J Gastroenterol Hepatol. Mar 2017;32 Suppl 1:5-7. doi: 10.1111/jgh.13685. PMID: 28244673. Resumen

  11. De Giorgio R, Volta U, Gibson PR. Sensitivity to wheat, gluten and FODMAPs in IBS: facts or fiction? Gut. Ene 2016;65(1):169-178. doi: 10.1136/gutjnl-2015-309757. PMID: 26078292. Artículo

  12. Staudacher HM, Whelan K. The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS. Gut. Ago 2017;66(8):1517-1527. doi: 10.1136/gutjnl-2017-313750. PMID: 28592442. Resumen

  13. Catassi G, Lionetti E, Gatti S, Catassi C. The Low FODMAP Diet: Many Question Marks for a Catchy Acronym. Nutrients. 16 Mar 2017;9(3). pii: E292. doi: 10.3390/nu9030292. PMID: 28300773. Artículo

  14. Hill P, Muir JG, Gibson PR. Controversies and Recent Developments of the Low-FODMAP Diet. Gastroenterol Hepatol (N Y). Ene 2017;13(1):36-45. PMID: 28420945. Artículo

  15. Lebwohl B, Green PH. Dietary therapy for irritable bowel syndrome. BMJ. 22 Jul 2016;354:i3902. doi: 10.1136/bmj.i3902. PMID: 27449185. Editorial

  16. Gibson P, Shepherd SJ. Personal view: food for thought--western lifestyle and susceptibility to Crohn's disease. The FODMAP hypothesis. Aliment Pharmacol Ther. 15 Jun 2005;21(12):1399-1409. doi: 10.1111/j.1365-2036.2005.02506.x. PMID: 15948806. Artículo

  17. Monash University. Low FODMAP Diet. Consultado el 1 de agosto de 2017. Disponible en: http://www.med.monash.edu/cecs/gastro/fodmap/low-high.html.

  18. Gibson PR. The evidence base for efficacy of the low FODMAP diet in irritable bowel syndrome: is it ready for prime time as a first-line therapy? J Gastroenterol Hepatol. Mar 2017;32 Suppl 1:32-35. doi: 10.1111/jgh.13693. PMID: 28244668. Artículo

  19. Eswaran SL, Chey WD, Han-Markey T, Ball S, Jackson K. A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D. Am J Gastroenterol. Dic 2016;111(12):1824-1832. doi: 10.1038/ajg.2016.434. PMID: 27725652. Resumen

  20. Eswaran S, Chey WD, Jackson K, Pillai S, y cols. A diet low in fermentable oligo-, di-, and mono-saccharides and polyols improves quality of life and reduces activity impairment in patients with irritable bowel syndrome and diarrhea. Clin Gastroenterol Hepatol. 28 Jun 2017. pii: S1542-3565(17)30791-7. doi: 10.1016/j.cgh.2017.06.044. PMID: 28668539. Resumen

  21. Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology. Ene 2014;146(1):67-75.e5. doi: 10.1053/j.gastro.2013.09.046. PMID: 24076059. Artículo

  22. Böhn L, Störsrud S, Liljebo T, Collin L, y cols. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology. Nov 2015;149(6):1399-1407. doi: 10.1053/j.gastro.2015.07.054. PMID: 26255043. Artículo

  23. Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal symptoms: the FODMAP approach. J Gastroenterol Hepatol. Feb 2010;25(2):252-258. doi: 10.1111/j.1440-1746.2009.06149.x. PMID: 20136989. Artículo

  24. Halmos EP, Christophersen CT, Bird AR, Shepherd SJ, y cols. Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut. Ene 2015;64(1):93-100. doi: 10.1136/gutjnl-2014-307264. PMID: 25016597. Artículo

  25. Rao S, Yu S, Fedewa A. Systematic review: dietary fiber and FODMAP- restricted diet in the management of constipation and the irritable bowel syndrome. Aliment Pharmacol Ther. Jun 2015;41(12):1256-1270. doi: 10.1111/apt.13167. PMID: 25903636. Artículo

  26. Staudacher HM, Irving PM, Lomer MC, Whelan K. Mechanisms and efficacy of dietary FODMAP restriction in IBS. Nat Rev Gastroenterol Hepatol. Abr 2014;11(4):256-266. doi: 10.1038/nrgastro.2013.259. PMID: 24445613. Artículo

  27. Eswaran S. Low FODMAP in 2017: Lessons learned from clinical trials and mechanistic studies. Neurogastroenterol Motil. Abr 2017;29(4). doi: 10.1111/nmo.13055. PMID: 28345807. Artículo

  28. de Roest R, Dobbs BR, Chapman BA, Batman B, y cols. The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study. Int J Clin Pract. Sep 2013;67(9):895-903. doi: 10.1111/ijcp.12128. PMID: 23701141. Artículo

  29. Krogsgaard LR, Lyngesen M, Bytzer P. Systematic review: quality of trials on the symptomatic effects of the low FODMAP diet for irritable bowel syndrome. Aliment Pharmacol Ther. Jun 2017;45(12):1506-1513. doi: 10.1111/apt.14065. PMID: 28440580. Artículo

  30. Marsh A, Eslick EM, Eslick GD. Does a diet low in FODMAPS reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur J Nutr. Abr 2016;55(3):897-906. doi: 10.1007/s00394-015-0922-1. PMID: 25982757. Resumen

  31. McIntosh K, Reed DE, Schneider T, Dang F, y cols. FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial. Gut. Jul 2017;66(7):1241-1251. doi: 10.1136/gutjnl-2015-311339. PMID: 26976734. Resumen

  32. Bennet SMP, Böhn L, Störsrud S, Liljebo T, y cols. Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs. Gut. 17 Abr 2017. pii: gutjnl-2016-313128. doi: 10.1136/gutjnl-2016-313128. PMID: 28416515. Resumen

  33. Chumpitazi BP, Cope JL, Hollister EB, Tsai CM, y cols. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Aliment Pharmacol Ther. Ago 2015;42(2):418-427. doi: 10.1111/apt.13286. PMID: 26104013. Artículo

  34. Hustoft TN, Hausken T, Ystad SO, Brokstad K, y cols. Effects of varying dietary content of fermentable short- chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome. Neurogastroenterol Motil. Abr 2017;29(4). doi: 10.1111/nmo.12969. PMID: 27747984. Artículo

  35. Staudacher HM, Lomer MCE, Farquharson FM, Louis P, y cols. Diet Low in FODMAPs reduces symptoms in patients with irritable bowel syndrome and probiotic restores bifidobacterium species: a randomized controlled trial. Gastroenterology. Oct 2017;153(4):936-947. doi: 10.1053/j.gastro.2017.06.010. PMID: 28625832. Artículo

  36. Wilson B, Rossi M, Parkes G, Aziz Q y cols. OC-026 Prebiotic b-galacto-oligosaccharides in conjunction with the low FODMAP diet improves symptoms of irritable bowel syndrome but does not prevent decline of bifidobacteria: a randomised controlled trial. Gut. 2017;66:A14. doi: 10.1136/gutjnl-2017-314472.26. Resumen

  37. Ford AC, Lacy BE, Talley NJ. Irritable Bowel Syndrome. N Engl J Med. 29 Jun 2017;376(26):2566-2578. doi: 10.1056/NEJMra1607547. PMID: 28657875. Resumen

Comentario

3090D553-9492-4563-8681-AD288FA52ACE
Los comentarios están sujetos a moderación. Por favor, consulte los Términos de Uso del foro

procesando....